期 |
标题 |
文件 |
卷 91, 编号 10 (2019) |
Diabetes mellitus and cognitive impairment |
 (Rus)
|
Surkova E., Tanashyan M., Bespalov A., Naminov A.
|
卷 91, 编号 10 (2019) |
Diabetic macroangiopathy |
 (Rus)
|
Verbovoy A., Pashentseva A., Verbovaya N.
|
卷 91, 编号 10 (2019) |
Central hypothyroidism |
 (Rus)
|
Petunina N., Trukhina L., Martirosian N.
|
卷 91, 编号 10 (2019) |
Eosinophilic inflammation in chronic obstructive pulmonary disease |
 (Rus)
|
Avdeev S., Trushenko N., Merzhoeva Z., Ivanova M., Kusraeva E.
|
卷 91, 编号 10 (2019) |
Diabetes epidemiology in Russia: what has changed over the decade? |
 (Rus)
|
Shestakova M., Vikulova O., Zheleznyakova A., Isakov M., Dedov I.
|
卷 91, 编号 9 (2019) |
Hypertrophic cardiomyopathy: modern aspects of pharmacologic treatment |
 (Rus)
|
Gudkova A., Streltsova A., Kostareva A.
|
卷 91, 编号 9 (2019) |
The importance of modern high - sensitivity troponin tests in the diagnosis of myocardial infarction without ST-segment elevation |
 (Rus)
|
Abaturova O., Suplotov S., Kremneva L., Shalaev S.
|
卷 91, 编号 9 (2019) |
Metastatic lesion of the right atrium with renal cell carcinoma |
 (Rus)
|
Isaev G., Mironova O., Yudakova M., Shakhnovish R., Fomin V.
|
卷 91, 编号 9 (2019) |
Therapeutic aspects of the choice of antithrombotic therapy in patients with multifocal lesions of peripheral arteries |
 (Rus)
|
Oynotkinova O., Nikonov E., Kryukov E., Baranov A.
|
卷 91, 编号 9 (2019) |
Risk stratification methods and their significance in pulmonary arterial hypertension |
 (Rus)
|
Avdeev S., Tsareva N.
|
卷 91, 编号 9 (2019) |
Galactin-3: diagnostic and prognostic value in patients with chronic heart failure |
 (Rus)
|
Aliyeva A., Baykova I., Kislyakov V., Gasanova E., Almazova I., Pinchuk T., Fedulayev Y., Zhbanov I., Perevertov V., Kovtyukh I., Nikitin I., Reznik E.
|
卷 91, 编号 9 (2019) |
Endovascular closure of a ventricular septal defect from Takotsubo Syndrome |
 (Rus)
|
Zhukova N., Merkulova I., Shakhnovich R., Merkulov E., Osiev A., Pevzner D., Sukhinina T., Staroverov I.
|
卷 91, 编号 9 (2019) |
Morphological and Immunohystochemical Characteristics of Aspirated Thrombi in Patients with ST-Elevation Myocardial Infarction |
 (Rus)
|
Sisakian H., Mkhitaryan A., Sahakyan V., Kocharyan A., Asatryan B.
|
卷 91, 编号 9 (2019) |
Full - transcriptome analysis of miRNA expression in mononuclear cells in patients with acute decompensation of chronic heart failure of various etiologies |
 (Rus)
|
Zhirov I., Baulina N., Nasonova S., Osmak G., Matveyeva N., Mindzaev D., Favorova O., Tereshchenko S.
|
卷 91, 编号 9 (2019) |
Thrombotic and hemorrhagic complications in atrial fibrillation patients, undergoing elective percutaneous coronary intervention |
 (Rus)
|
Krivosheeva E., Kropacheva E., Panchenko E., Samko A.
|
卷 91, 编号 9 (2019) |
Antihypertensive therapy in men and women in real clinical practice according to the National register |
 (Rus)
|
Oshhepkova E., Aksenova A., Orlovskij A., Chazova I.
|
卷 91, 编号 9 (2019) |
Possibilities of cardioselective beta - blocker bisoprolol therapy in patients having coronary artery disease and bronchial asthma |
 (Rus)
|
Grigorieva N., Ilyushina T., Yashina E.
|
卷 91, 编号 9 (2019) |
Treatment of ARVI and influenza in patients with arterial hypertension |
 (Rus)
|
Silina E., Sitnikov I., Fazylov V., Yeganyan G.
|
卷 91, 编号 9 (2019) |
Epicardial adipose tissue as a marker of visceral obesity and its association with metabolic parameters and remodeling of the left chambers of the heart in young people with abdominal obesity |
 (Rus)
|
Blinova N., Azimova M., Zhernakova Y., Zheleznova E., Yarovaya E., Orlovskiy A., Azimova M., Dobrovolskaya S., Ternovoy S., Chazova I.
|
卷 91, 编号 9 (2019) |
Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry |
 (Rus)
|
Chazova I., Valieva Z., Nakonechnikov S., Taran I., Martynyuk T.
|
卷 91, 编号 9 (2019) |
Autoantibodies to M2-cholinoreceptors as a potential development factor of arrhythmia in patients with paroxysmal atrial fibrillation |
 (Rus)
|
Mironova E., Mironova N., Sharf T., Efremov E., Azmuko A., Molokoedov A., Zykov K., Golitsyn S.
|
卷 91, 编号 9 (2019) |
Comparative efficacy and safety of enoxaparin followed by warfarin and rivaroxaban monotherapy in the treatment of venous thrombosis in patients after intracardiac catheter interventions |
 (Rus)
|
Loginova A., Kropacheva E., Maykov E., Balakhonova T., Golitsyn S.
|
卷 91, 编号 9 (2019) |
Preprocedural high - sensitivity C-reactive protein (hsCRP) decrease during intensive atorvastatin therapy: the presumable impact on atherosclerosis progression after coronary stenting |
 (Rus)
|
Shchinova A., Shlevkova G., Filatova A., Potekhina A., Osokina A., Romasov I., Zharova E., Noeva E., Samko A., Masenko V., Arefieva T., Provatorov S.
|
卷 91, 编号 9 (2019) |
Exercise training and erectile dysfunction in patients after coronary artery bypass grafting |
 (Rus)
|
Pomeshkina S., Barbarash O., Pomeshkin E.
|
卷 91, 编号 9 (2019) |
Endothelial dysfunction in patients with controlled and uncontrolled arterial hypertension |
 (Rus)
|
Podzolkov V., Safronova T., Natkina D.
|
卷 91, 编号 9 (2019) |
Cardiogenic shock in patients with acute coronary syndrome (data from Russian Federal Acute Coronary Syndrome Registry) |
 (Rus)
|
Sagaydak O., Oschepkova E., Chazova I.
|
卷 91, 编号 9 (2019) |
Fibrinolytics: from the thrombolysis to the processes of blood vessels growth and remodeling, neurogenesis, carcinogenesis and fibrosis |
 (Rus)
|
Tkachuk V., Parfyonova Y., Plekhanova O., Stepanova V., Menshikov M., Semina E., Bibilashvili R., Chazov E.
|
卷 91, 编号 8 (2019) |
Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation |
 (Rus)
|
Knyazev O., Shkurko T., Kagramanova A., Lishchinskaya A., Zvyaglova M., Korneeva I., Babayan A., Parfenov A.
|
卷 91, 编号 8 (2019) |
Methanobrevibacter smithii in irritable bowel syndrome: a clinical and molecular study |
 (Rus)
|
Vlasova A., Isakov V., Pilipenko V., Sheveleva S., Markova Y., Polyanina A., Maev I.
|
卷 91, 编号 8 (2019) |
Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection |
 (Rus)
|
Maev I., Andreev D., Kucheryavyy Y., Shaburov R.
|
卷 91, 编号 8 (2019) |
Follicular lymphoma: first - line selection criteria of treatment |
 (Rus)
|
Nesterova E., Kravchenko S., Kovrigina A., Gemdzhian E., Plastinina L., Babaeva F., Obukhova T., Magomedova A., Gaponova T., Kremenetskaya A., Vorobyev A.
|
卷 91, 编号 8 (2019) |
Glucocorticosteroids for people with alcoholic hepatitis (Cochrane review) |
 (Rus)
|
Pavlov C., Varganova D., Casazza G., Tsochatzis E., Nikolova D., Gluud C.
|
卷 91, 编号 8 (2019) |
Efficacy and safety of narlaprevir/ritonavir and daclatasvir non interferon combination in population of Russian patients with chronic hepatitis C |
 (Rus)
|
Klimova E., Burnevich E., Chulanov V., Gusev D., Znoyko O., Batskikh S., Kizlo S., Mamonova N., Tarkhova E., Krasavina E., Samsonov M., Yushchuk N.
|
卷 91, 编号 8 (2019) |
Treatment of candidemia caused by Candida albicans and Candida non - albicans in patients with hematological malignancies |
 (Rus)
|
Klyasova G., Malchikova A., Tandilova K., Blohina E., Parovichnikova E., Kravchenko S., Savchenko V.
|
卷 91, 编号 8 (2019) |
Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors |
 (Rus)
|
Rytkin E., Mirzaev K., Bure I., Sychev D.
|
卷 91, 编号 8 (2019) |
Evaluation of the efficiency of combined pharmacotherapy with the use of trimetazidine with prolonged release in patients with stable angina in outpatient practice |
 (Rus)
|
Luneva Y., Povetkin S.
|
卷 91, 编号 8 (2019) |
Patient's way from acute pulmonary embolism to chronic thromboembolic pulmonary hypertension: diagnostic and treatment options |
 (Rus)
|
Edemskiy A., Ivanov S., Kliver E., Novikova N., Galstyan M., Sevastyanov A., Cherniavsky A.
|
卷 91, 编号 8 (2019) |
Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation |
 (Rus)
|
Balzhanova Y., Parovichnikova E., Sokolov A., Ryzhko V., Samtsova M., Gribanova E.
|
卷 91, 编号 8 (2019) |
Analysis of the effectiveness of joint or sequential vaccination with pneumococcal and influenza vaccines in patients with chronic obstructive pulmonary disease |
 (Rus)
|
Ignatova G., Antonov V., Blinova E.
|
卷 91, 编号 8 (2019) |
New directions of pharmacotherapy of immune - inflammatory rheumatic diseases |
 (Rus)
|
Nasonov E.
|
卷 91, 编号 8 (2019) |
Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β |
 (Rus)
|
Bakulina N., Maev I., Savilova I., Bakulin I., Il'chishina T., Zagorodnikova K., Murzina A., Andreev D.
|
卷 91, 编号 8 (2019) |
The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease |
 (Rus)
|
Veliev A., Maev I., Andreev D., Dicheva D., Zaborovskii A., Lobanova E., Bektemirova L.
|
卷 91, 编号 8 (2019) |
Comparative clinical and economic evaluation of pharmacogenetic testing application for dabigatran in patients with atrial fibrillation |
 (Rus)
|
Abdullaev S., Mirzaev K., Sychev D.
|
卷 91, 编号 8 (2019) |
The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications |
 (Rus)
|
Ostroumova O., Kochetkov A., Pereverzev A., Kravchenko E., Kazjulin A., Andreev D., Pavleeva E.
|
卷 91, 编号 8 (2019) |
Hypervitaminosis B12 - a new marker and predictor of prognostically unfavorable diseases |
 (Rus)
|
Podzolkov V., Dragomiretskaya N., Dambaeva O., Auvinen S., Medvedev I.
|
卷 91, 编号 8 (2019) |
Diagnosis and treatment of acute low back pain |
 (Rus)
|
Parfenov V., Golovacheva V.
|
卷 91, 编号 8 (2019) |
Underwater rocks of anti - helicobacter therapy |
 (Rus)
|
Livzan M.
|
卷 91, 编号 8 (2019) |
Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem |
 (Rus)
|
Osadchuk A., Davydkin I., Gricenko T., Osadchuk M.
|
卷 91, 编号 8 (2019) |
The clinical significance of disorders of the motor function of the esophagus, stomach and duodenum |
 (Rus)
|
Trukhmanov A., Ivashkina N.
|
卷 91, 编号 8 (2019) |
Some practical issues in the management of patients with decompensated liver cirrhosis |
 (Rus)
|
Fedosina E., Byeverov A., Bogomolov P., Staroverova N.
|
卷 91, 编号 7 (2019) |
The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data |
 (Rus)
|
Misyurina A., Kravchenko S., Kovrigina A., Magomedova A., Plastinina L., Obukhova T., Misyurin A., Misyurin V., Grebenuk L., Babaeva F., Baryakh E., Vorobiev A.
|
卷 91, 编号 7 (2019) |
Role of the intensive care in treatment of patients with acute myeloid leukemia |
 (Rus)
|
Bazhenov A., Galstyan G., Parovichnikova E., Troitskaya V., Kuzmina L., Fidarova Z., Gribanova E., Makhinya S., Latyshkevich O., Chabaeva U., Kulikov S., Savchenko V.
|
卷 91, 编号 7 (2019) |
Brain MRI-findings in Ph - negative myeloproliferative disorders |
 (Rus)
|
Tanashyan M., Melikyan A., Kuznetsova P., Raskurazhev A., Shabalina A., Konovalov R.
|
卷 91, 编号 7 (2019) |
CNS involvement and the feasibility of intratecal chemotherapy administration in patients with a nodal form of diffuse large B-cell lymphoma not otherwise specified. Data of prospective study |
 (Rus)
|
Magomedova A., Misyurina A., Mangasarova J., Gorenkova L., Margolin O., Fastova E., Kravchenko S.
|
卷 91, 编号 7 (2019) |
Molecular diagnosis angioimmunoblastic T-cell lymphoma |
 (Rus)
|
Chernova N., Sidorova Y., Smirnova S., Ryzhikova N., Nikulina E., Kovrigina A., Sinitsyna M., Sudarikov A.
|
卷 91, 编号 7 (2019) |
Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma |
 (Rus)
|
Vorobyev V., Gemdzhian E., Dubrovin E., Nesterova E., Kaplanov K., Volodicheva E., Zherebtsova V., Kravchenko S.
|
卷 91, 编号 7 (2019) |
Difficulties evaluating hematological response in patients with multiple myeloma and dialysis - dependent renal impairment |
 (Rus)
|
Rekhtina I., Mendeleeva L., Soboleva N.
|
卷 91, 编号 7 (2019) |
Clinical observation of a patient with thrombotic thrombocytopenic purpura with renal and intestinal lesions |
 (Rus)
|
Stolyar A., Avdonin P., Valamina I., Stolyarevich E.
|
卷 91, 编号 7 (2019) |
Clinical case of IgG4-related disease in a patient with Burkitt lymphoma |
 (Rus)
|
Feydorova T., Vinokurova L., Dvoynikov S., Mikheeva O., Dudin G., Akopova A.
|
卷 91, 编号 7 (2019) |
Russian multicenter clinical trials in acute leukemias |
 (Rus)
|
Parovichnikova E., Savchenko V.
|
卷 91, 编号 7 (2019) |
Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome |
 (Rus)
|
Melikyan A., Subortseva I., Koloshejnova E., Gilyazitdinova E., Shashkina K., Gorgidze L., Tratsevskaya Z., Margolin O.
|
卷 91, 编号 7 (2019) |
Personalized approach for direct oral anticoagulant prescription: from theory to practice |
 (Rus)
|
Skripka A., Kogay V., Listratov A., Sokolova A., Napalkov D., Fomin V.
|
卷 91, 编号 7 (2019) |
Epidemiology of multiple myeloma in city Moscow |
 (Rus)
|
Vinogradova O., Ptushkin V., Chernikov M., Kochkareva Y., Zherebtsova V.
|
卷 91, 编号 7 (2019) |
Pure red cell aplasia of the bone marrow in combination with thymoma. A literature review and own data |
 (Rus)
|
Petrenko A., Pivnik A., Dudina G., Dubnitskaya M.
|
卷 91, 编号 7 (2019) |
Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases |
 (Rus)
|
Olkhovskiy I., Gorbenko A., Stolyar M., Grischenko D., Tkachenko O., Martsinkevich T.
|
卷 91, 编号 7 (2019) |
PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients |
 (Rus)
|
Solovev M., Mendeleeva L., Firsova M., Aslanidi I., Mukhortova O., Savchenko V.
|
卷 91, 编号 7 (2019) |
Enzyme replacement therapy in adult patients with type I Gaucher disease |
 (Rus)
|
Ponomarev R., Lukina E.
|
卷 91, 编号 5 (2019) |
Alflutop - in modern symptom - modifying osteoarthritis therapy |
 (Rus)
|
Drozdov V., Shikh E., Serebrova S., Abrosimov A., Starodubtsev A.
|
卷 91, 编号 5 (2019) |
Chronic kidney disease in rheumatoid arthritis patients: prevalence, risks factors, histopathological variants |
 (Rus)
|
Chebotareva N., Guliaev S., Androsova T., Milivanova L.
|
卷 91, 编号 5 (2019) |
Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy |
 (Rus)
|
Eliseev M., Novikova A.
|
卷 91, 编号 5 (2019) |
Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm |
 (Rus)
|
Sokol E., Vasilyev V., Palshina S., Kokosadze N., Probatova N., Kovrigina A., Safonova T., Rodionova E., Gaiduk I., Selifanova E.
|
卷 91, 编号 5 (2019) |
Vitamin D - prognostic marker of the risk of exacerbation in patients older than 60 years with osteoarthritis of the knee (results of the observation program DIANA) |
 (Rus)
|
Zolotovskaya I., Davydkin I.
|
卷 91, 编号 5 (2019) |
The сhanges of bone mineral density on the risk of progression of osteoarthritis of the knee |
 (Rus)
|
Kashevarova N., Taskina E., Alekseeva L., Demin N., Lila A., Nasonov E.
|
卷 91, 编号 5 (2019) |
Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment |
 (Rus)
|
Gerasimova E., Popkova T., Martynova A., Markelova E., Novikova D., Kirillova I.
|
卷 91, 编号 5 (2019) |
The role of laboratory biomarkers in monitoring of rituximab biosimilar therapy (Acellbia, “BIOCAD”) in patients with rheumatoid arthritis |
 (Rus)
|
Avdeeva A., Cherkasova M., Kusevich D., Rybakova V., Artyuhov A., Dashinimaev E., Chichasova N., Nasonov E.
|
卷 91, 编号 5 (2019) |
What factors affect the effectiveness of long - term analgesic therapy for osteoarthritis? Data analysis of the multi - center 3-month PARACELSUS study |
 (Rus)
|
Karateev A., Lila A., Pogozheva E., Amirdzhanova V., Filatova E.
|
卷 91, 编号 5 (2019) |
Intestinal manifestations of Behçet's disease |
 (Rus)
|
Goloeva R., Alekberova Z., Lisitsyna T., Stepanova E., Orlova L.
|
卷 91, 编号 5 (2019) |
Pulmonary hemorrhage in rheumatic diseases |
 (Rus)
|
Kraeva V., Beketova T.
|
卷 91, 编号 5 (2019) |
Chronic pain and depression in patients with rheumatoid arthritis: results of five - year follow - up |
 (Rus)
|
Lisitsyna T., Abramkin A., Veltishchev D., Seravina O., Kovalevskaya O., Zeltyn A., Glukhova S., Nasonov E., Krasnov V.
|
卷 91, 编号 5 (2019) |
Spondyloarthritis: modern terminology and definitions |
 (Rus)
|
Erdes S., Rebrov A., Dubinina T., Badokin V., Bochkova A., Bugrova O., Gaydukova I., Godzenko A., Dubikov A., Ivanova O., Korotaeva T., Lapshina S., Nesmeyanova O., Nikishina I., Otteva E., Raskina T., Rumyantseva O., Sitalo A., Smirnov A.
|
卷 91, 编号 5 (2019) |
Endothelial damage and circadian blood pressure profile in rheumatoid arthritis |
 (Rus)
|
Shilkina N., Yunonin I., Butusova S., Mikhailova E., Vinogradov A.
|
卷 91, 编号 5 (2019) |
Sjögren's syndrome with juvenile onset |
 (Rus)
|
Kaleda M., Nikishina I., Latypova A.
|
卷 91, 编号 5 (2019) |
The effectiveness of complex therapy using the injectable form of chondroitin sulfate and sodium hyaluronate with osteoarthritis of the knee joint |
 (Rus)
|
Belyaeva E., Avdeeva O.
|
卷 91, 编号 5 (2019) |
Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range |
 (Rus)
|
Seredavkina N., Reshetnyak T., Satybaldyeva M., Kashnikova L., Temnikova T., Nasonov E.
|
卷 91, 编号 5 (2019) |
Rheumatoid arthritis: achievements and unresolved issues |
 (Rus)
|
Nasonov E., Lila A.
|
卷 91, 编号 5 (2019) |
Idiopatic Lobular Panniculitis as a common clinical problem |
 (Rus)
|
Egorova O., Belov B., Glukhova S., Radenska-Lopovok S.
|
卷 91, 编号 4 (2019) |
Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease |
 (Rus)
|
Danilova N., Abdulkhakov S., Grigoryeva T., Markelova M., Vasilyev I., Boulygina E., Ardatskaya M., Pavlenko A., Tyakht A., Odintsova A., Abdulkhakov R.
|
卷 91, 编号 4 (2019) |
Hepatic involvement in sarcoidosis |
 (Rus)
|
Fomin V., Brovko M., Kalashnikov M., Sholomova V., Rozina T., Akulkina L., Pershina A., Yanakayeva A., Nekrasova T.
|
卷 91, 编号 4 (2019) |
Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis |
 (Rus)
|
Kurbatova I., Topchieva L., Dudanova O., Shipovskaya A.
|
卷 91, 编号 4 (2019) |
The value of cardiovascular magnetic resonance in myocarditis with different clinical presentation |
 (Rus)
|
Stukalova O., Gupalo E., Chumachenko P., Samko A., Butorova E., Shakhnovich R., Mironova N., Narusov O., Safiullina A., Golitsyn S., Ternovoy S., Chazova I.
|
卷 91, 编号 4 (2019) |
Role of video capsulе endoscopy in the diagnostic algorithm of small bowel Crohn's disease |
 (Rus)
|
Parfenov A., Akopova A., Shcherbakov P., Mikcheeva O.
|
卷 91, 编号 4 (2019) |
Neurological disorders in vitamin B12 deficiency |
 (Rus)
|
Pavlov C., Damulin I., Shulpekova Y., Andreev E.
|
卷 91, 编号 4 (2019) |
Diagnostic difficulties of primary hemochromatosis in a patient with posthemorrhagic anemia |
 (Rus)
|
Podzolkov V., Pokrovskaya A., Vargina T., Oganesyan K.
|
卷 91, 编号 4 (2019) |
Unsolved issues of pregnancy in liver cirrhosis |
 (Rus)
|
Kotzev A., Tanchev L., Pavlov C., Tanchev S.
|
卷 91, 编号 4 (2019) |
Gray-zone lymphoma. Examples of rare clinical manifestation |
 (Rus)
|
Misyurina A., Kravchenko S., Mangasarova Y., Magomedova A., Kovrigina A., Shimanovskaya L., Fastova E., Misyurin V., Model S., Chebotarev D., Kostina I., Savchenko V.
|
卷 91, 编号 4 (2019) |
Morphologically proved ANCA positive Loeffler’s pancarditis: medical and surgical treatment |
 (Rus)
|
Blagova O., Aliyeva I., Nedostup A., Kogan E., Komarov R., Chernyavsky S., Seslavinskaya V., Shelukha P., Sedov V., Gagarina N., Mershina E., Sinitsyn V., Fomin V.
|
卷 91, 编号 4 (2019) |
ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high risk |
 (Rus)
|
Sergienko I., Ansheles A., Drapkina O., Gornyakova N., Zubareva M., Shepel R., Kuharchuk V., Boytsov S.
|
卷 91, 编号 4 (2019) |
New ECG criteria for differential diagnosis of wide QRS complex tachycardias with right bundle branch block pattern |
 (Rus)
|
Shlevkov N., Salami H., Kiktev V., Sokolov S.
|
卷 91, 编号 4 (2019) |
Various approaches for peforming an outpatient coronary angiography |
 (Rus)
|
Danilushkin Y., Matchin Y., Shamrina N., Bubnov D., Atanesyan R., Mitroshkin M., Basinkevich A., Ageev F.
|
卷 91, 编号 4 (2019) |
Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension |
 (Rus)
|
Danilov N., Matchin Y., Chernyavsky A., Edemsky A., Grankin D., Sagaydak O., Chazova I., Boytsov S., Karaskov A.
|
卷 91, 编号 4 (2019) |
The marker of adverse prognosis 1.5-anhydroglucitol in patients with coronary heart disease in the long-term period after planned myocardial revascularization |
 (Rus)
|
Ignatova Y., Karetnikova V., Horlampenko A., Gruzdeva O., Dyleva Y., Barbarash O.
|
卷 91, 编号 4 (2019) |
O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov |
 (Rus)
|
Knyazev O., Kagramanova A., Korneeva I., Noskova K., Belousov S., Parfenov A.
|
卷 91, 编号 4 (2019) |
Clinical significance of lipohypertrophy without visual and palpable changes detected by ultrasonography of subcutaneous fat |
 (Rus)
|
Volkova N., Davidenko I.
|
卷 91, 编号 4 (2019) |
Early diagnosis of acute renal injury in patients with acute decompensation of chronic heart failure |
 (Rus)
|
Nasonova S., Zhirov I., Ledyakhova M., Sharf T., Bosykh E., Masenko V., Tereshchenko S.
|
卷 91, 编号 4 (2019) |
Akademik Valentin Ivanovich Pokrovskiy (k 90-letiyu so dnya rozhdeniya) |
|
- -.
|
卷 91, 编号 4 (2019) |
The role of perivascular adipose tissue in the development of cardiovascular diseases. The importance of diagnosis for assessing the risk stratification of cardiovascular diseases |
 (Rus)
|
Uchasova E., Gruzdeva O., Dyleva Y., Belik E.
|
卷 91, 编号 3 (2019) |
Features of the current of bronchial asthma in the presence of komorbidy allergic rhinitis |
 (Rus)
|
Zaripova T., Antipova I., Reshetova G.
|
卷 91, 编号 3 (2019) |
Combination of community acquired pneumonia with chronic obstructive pulmonary disease: clinical peculiarities, production of active oxygen forms, general antioxidant blood status |
 (Rus)
|
Farkhutdinov U., Amirova E., Farkhutdinov R.
|
卷 91, 编号 3 (2019) |
Clinical efficacy of acute respiratory viral infections prevention in patients with chronic heart failure |
 (Rus)
|
Budnevsky A., Shurupova A., Kravchenko A., Tokmachev R.
|
卷 91, 编号 3 (2019) |
Destruction of the bronchial epithelium in patients with severe asthma according to different patterns of inflammation and cold airway hyperresponsiveness |
 (Rus)
|
Pirogov A., Gassan D., Zinov’ev S., Prikhodko A., Kolosov V., Perelman J.
|
卷 91, 编号 3 (2019) |
Association of SOCS5 gene polymorphism with allergic bronchial asthma |
 (Rus)
|
Averyanov A., Chercashina I., Nikulina S., Maksimov V., Shestovitskiy V.
|
卷 91, 编号 3 (2019) |
Clinical releveance of hemorrhagic component of endobronchial inflammation in severe chronic obstructive pulmonary disease exacerbation |
 (Rus)
|
Shteiner M., Zhestkov A., Babanov S., Biktagirov I., Protasov A., Kulagina V., Budash D., Zolotov M.
|
卷 91, 编号 3 (2019) |
Comparison of the integral indices of the vectorcardiogram with the data of echocardiography in patients with idiopathic and chronic thromboembolic pulmonary hypertension |
 (Rus)
|
Sakhnova T., Blinova E., Belevskaya A., Saidova M., Arkhipova O., Yurasova E., Alokova F., Martynyuk T., Chazova I.
|
卷 91, 编号 3 (2019) |
Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension) |
 (Rus)
|
Chazova I., Lazareva N., Oshchepkova E.
|
卷 91, 编号 3 (2019) |
Endothelial dysfunction in patients with chronic obstructive pulmonary disease in combination with coronary heart disease |
 (Rus)
|
Karoli N., Rebrov A.
|
卷 91, 编号 3 (2019) |
Indicators of immunological and hormonal research in patients with non-hospital pneumonia-liquidators of the Chernobyl accident after treatment |
 (Rus)
|
Selihova L., Borzykh O., Lavrenko A., Digtiar N., Gerasymenko N.
|
卷 91, 编号 3 (2019) |
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR) |
 (Rus)
|
Pshenichnaya N., Bulgakova V., Lvov N., Poromov A., Selkova E., Grekova A., Shestakova I., Maleev V., Leneva I.
|
卷 91, 编号 3 (2019) |
Expert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension" |
 (Rus)
|
Chazova I., Martynyuk T.
|
卷 91, 编号 3 (2019) |
Pneumoconiosises: modern view |
 (Rus)
|
Babanov S., Strizhakov L., Lebedeva M., Fomin V., Budash D., Baikova A.
|
卷 91, 编号 3 (2019) |
Multidisciplinary approach in the diagnosis of idiopathic nonspecific interstitial pneumonia |
 (Rus)
|
Ovcharenko S., Son E., Kapustina V.
|
卷 91, 编号 3 (2019) |
Respiratory muscles dysfunction and respiratory diseases |
 (Rus)
|
Geltser B., Kurpatov I., Dej A., Kozhanov A.
|
卷 91, 编号 3 (2019) |
Possibilities of ultrasound research of the diaphragm |
 (Rus)
|
Nekludova G., Avdeev S.
|
卷 91, 编号 3 (2019) |
New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease |
 (Rus)
|
Avdeev S., Trushenko N.
|
卷 91, 编号 3 (2019) |
Cough: the evolution of views and modern approaches to an objective assessment |
 (Rus)
|
Budnevskiy A., Ovsyannikov E., Shkatova Y., Rezova N.
|
卷 91, 编号 3 (2019) |
High altitude pulmonary edema misdiagnosed as pneumonia |
 (Rus)
|
Sarybaev A., Maripov A., Muratali-Uulu K., Cholponbaeva M., Kushubakova N., Sydykov A.
|
卷 91, 编号 3 (2019) |
Difficulties in Goodpasture's syndrome diagnosing |
 (Rus)
|
Podzolkov V., Makhnach G., Ishina T., Ponomarev A., Medvedev I.
|
卷 91, 编号 2 (2019) |
Risk factors of unfavorable prognosis of chronic hepatitis C |
 (Rus)
|
Shchanitcyna S., Burnevich E., Nikulkina E., Filatova A., Moiseev S., Mukhin N.
|
卷 91, 编号 2 (2019) |
Possibilities of therapeutic correction of hyperammonemia and minimal hepatic encephalopathy in patients with chronic hepatitis C at the pre-cirrhotic stage |
 (Rus)
|
Buyeverov A., Bogomolov P., Mayev I., Matsievich M., Uvarova O.
|
卷 91, 编号 2 (2019) |
Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis |
 (Rus)
|
Vakhrushev Y., Lukashevich A., Penkina I., Suchkova E.
|
卷 91, 编号 2 (2019) |
Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B |
 (Rus)
|
Ibragimov E., Abdurakhmanov D., Rozina T., Nikulkina E., Tanaschuk E., Odintsov A., Panevkina S., Moiseev S.
|
卷 91, 编号 2 (2019) |
Prediction of features of the course of chronic hepatitis C using Bayesian networks |
 (Rus)
|
Samokhodskaya L., Starostina E., Sulimov A., Krasnova T., Rosina T., Avdeev V., Savkin I., Sulimov V., Mukhin N., Tkachuk V., Sadovnichii V.
|
卷 91, 编号 2 (2019) |
Rebamipide increases the disaccharidases activity in patients with enteropathy with impaired membrane digestion. Pilot study |
 (Rus)
|
Parfenov A., Belostotsky N., Khomeriki S., Akhmadullina O., Bykova S., Sabelnikova E., Dbar S.
|
卷 91, 编号 2 (2019) |
European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years |
 (Rus)
|
Bordin D., Embutnieks Y., Vologzhanina L., Ilchishina T., Voynovan I., Sarsenbaeva A., Zaitsev O., Alekseenko S., Abdulkhakov R., Dehnich N., Osipenko M., Livzan M., Tsukanov V., Burkov S., Bakulina N., Plotnikova E., Tarasova L., Maev I., Kucheryavyi Y., Baryshnikova N., Butov M., Kolbasnikov S., Pakhomova A., Zhestkova T., Baranovsky A., Abdulhakov S., Ageeva E., Lyalyukova E., Vasyutin A., Golubev N., Savilova I., Morkovkina L., Kononova A., Megraud F., O'Morain C., Ramas M., Nyssen O., McNicholl A., Gisbert J.
|
卷 91, 编号 2 (2019) |
Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018) |
 (Rus)
|
Vinnitskaya E., Abdulkhakov S., Abdurakhmanov D., Alikhanov R., Bakulin I., Belousova E., Bueverov A., Burnevitch E., Efanov M., Eremina E., Ignatova T., Ilchenko L., Karmazanovsky G., Knyazev O., Kulezneva Y., Lopatkina T., Nekrasova T., Nikitin I., Pavlenko V., Parfenov A., Podymova S., Raichelson K., Reisis A., Sayfutdinov R., Skazyvaeva E., Syutkin V., Khomeriki S., Haimenova T., Sandler Y.
|
卷 91, 编号 2 (2019) |
Small intestinal diverticula |
 (Rus)
|
Parfenov A., Krums L., Pavlov M.
|
卷 91, 编号 2 (2019) |
Prognosis factors of survival in patients with liver cirrhosis and portal hypertension |
 (Rus)
|
Olevskaya E., Dolgushina A., Tarasov A., Hihlova A.
|
卷 91, 编号 2 (2019) |
Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study |
 (Rus)
 (Eng)
|
Nadinskaia M., Kodzoeva K., Ulyanova K., Rogacheva S., Volkova A., Dekhanov A., Strelkova D., Ivashkin V.
|
卷 91, 编号 2 (2019) |
The state of the immune system in abdominal sepsis |
 (Rus)
|
Koshelev R., Vatazin A., Zulkarnayev A., Faenko A.
|
卷 91, 编号 2 (2019) |
Gene therapy of type 2 diabetes mellitus: state of art |
 (Rus)
|
Stafeev Y., Menshikov M., Parfyonova Y.
|
卷 91, 编号 2 (2019) |
Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease |
 (Rus)
|
Akhmedov V., Gaus O.
|
卷 91, 编号 2 (2019) |
Ademethionine in the treatment of fatigue in liver diseases: a systematic review |
 (Rus)
|
Raikhelson K., Kondrashina E.
|
卷 91, 编号 2 (2019) |
Phenotype of obesity and gastroesophageal reflux disease in the context of comorbidity in patients with cardiovascular diseases |
 (Rus)
|
Maev I., Yurenev G., Mironova E., Yureneva-Thorzhevskaya T.
|
卷 91, 编号 2 (2019) |
Vitamins in diet of patients with metabolic syndrome |
 (Rus)
|
Kodentsova V., Risnik D., Sharafetdinov K., Nikityuk D.
|
卷 91, 编号 2 (2019) |
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy |
 (Rus)
|
Maevskaya M., Ivashkin V., Ivashkin K., Lunkov V., Liusina E., Zozula V., Leshchenko V.
|
卷 91, 编号 2 (2019) |
The use of Tofacitinib in the treatment of inflammatory bowel disease |
 (Rus)
|
Nasonov E., Abdulganieva D., Fairushina I.
|
卷 91, 编号 2 (2019) |
Capsule endoscopy for diagnosis of celiac disease |
 (Rus)
|
Alimetov A., Poliakov P., Onopriev A., Avakimyan A., Zanin S., Kade A.
|
卷 91, 编号 2 (2019) |
Celiac disease associated with ulcerative colitis |
 (Rus)
|
Krums L., Babaian A., Bykova S., Lishchinskaia A., Khomeriki S., Gudkova R., Sabel'nikova E., Kniazev O., Parfenov A.
|
卷 91, 编号 2 (2019) |
MutYH-associated polyposis |
 (Rus)
|
Toboeva M., Shelygin Y., Frolov S., Kuzminov M., Tsukanov A.
|
卷 91, 编号 1 (2019) |
Safety of nonsteroidal anti-inflammatory drugs in patients with cardiovascular risk |
 (Rus)
|
Naumov A., Tkacheva O., Khovasova N.
|
卷 91, 编号 1 (2019) |
Protective measures of patients with cardiovascular diseases from exposure to heat waves: medicated and non-medicated |
 (Rus)
|
Smirnova M., Svirida O., Ageev F.
|
151 - 300 的 3196 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 > >>
|